For many ordinary families that cannot have children naturally, assisted reproduction is a suitable way to realize their "fertility dream", but its high cost makes many families prohibitive. Since 2023, my country

Some provinces have includedassisted reproduction in medical insurance reimbursement tosolve the problem of families who are willing to have children that "cannot and dare not have children" and help long-term balanced development of the population.

From "liberalizing three children" to this year's government work report clearly proposing "improving fertility support policies...

From "let go of the three children" to this year's government work report, it clearly puts forward "a sound fertility support policy.... reduce the burden of family childbirth, parenting, and education." A number of maternity support policies provide

A new requirement has been made.

According to relevant information, Beijing, Guangxi, Inner Mongolia, and Gansu provinces have successively included assisted reproduction in the scope of medical insurance reimbursement. Taking Guangxi as an example, starting from November 1, 2023, in vitro baby embryos

Twelve therapeutic assisted reproduction projects, including transplantation, have been included in the scope of medical insurance reimbursement. The medical insurance fund expenditure is approximately 114 million yuan, and the reimbursement rate reaches 59.13%. About 55,800 people enjoy this reimbursement policy

. This data fully demonstrates the efforts made by the National Health Insurance Administration to reduce the burden on patients. After assisted reproduction has been included in medical insurance reimbursement, it has greatly mobilized the enthusiasm of groups in need of fertility treatment.

In the past few months, the number of outpatient visits in assisted reproductive institutions across the autonomous region has reached 607,700, a year-on-year increase of 35.64%.

Including the cost of assisted reproductive treatment into national medical insurance is a major advancement in my country's medical security system. This measure will not only benefit the majority of patients, but also promote assisted reproductive technology in my country

Development of

. Prior to this, the charging standards for assisted reproductive technologies varied from region to region, and the overall level was at a relatively high level. Taking IVF as an example, the cost of a complete treatment cycle is about 30,000 to 5,000. 

Ten thousand yuan, and for some families that need to try multiple times, the cost can even reach hundreds of thousands of yuan. For ordinary families, such expenses undoubtedly constitute a heavy burden. Today, with

With the implementation of the medical insurance reimbursement policy, this problem has been effectively alleviated.

Take Ms. Zhang as an example. Suppose she is undergoing intracytoplasmic single sperm injection (ICSI, Second Generation IVF) treatment in the hospital. Before being included in medical insurance, the cost of oocyte retrieval (24

00 yuan), single sperm injection (3346 yuan), embryo culture (4200 yuan), and embryo transfer (2300 yuan) totaled 12246 yuan. After being included in medical insurance, Ms. Ruo Zhang participated in basic medical insurance for employees

Insurance personnel, according to a reimbursement ratio of 70%, the above four expenses only need to be paid 720 yuan, 1,003.8 yuan, 1260 yuan, and 690 yuan respectively, totaling 3,673.8 yuan, and 8,572.2 yuan can be reimbursed; if

Ms. Zhang is a participant in the basic medical insurance for urban and rural residents. According to the reimbursement ratio of 50%, the above four expenses are only required to pay 1200 yuan, 1673 yuan, 2100 yuan, and 1150 yuan respectively, totaling

 6123 yuan, 6123 yuan can be reimbursed. The final reimbursement fee depends on the patient's specific treatment conditions.

How much can assisted reproductive technology save after it is included in medical insurance reimbursement? According to China Business News, experts said that the cost of a single cycle of IVF in Beijing is about 30,000 to 50,000.

yuan. According to the median, medical insurance reimbursement expenses account for about 23% of the treatment expenses in a single cycle, and the reimbursement price is about 8000 to 11000 yuan.

After

decades of ups and downs, China has experienced a policy shift from family planning to encouraging two and three children. With the implementation of assisted reproduction into the medical insurance policy, it will give a certain boost to the industry.

used. According to relevant policies and regulations, the scope and proportion of medical insurance reimbursement will vary from region to region and hospital, but overall, medical insurance can reduce a certain financial burden on families.

In short, including the cost of assisted reproductive treatment into national medical insurance is an important advancement in my country's medical security system. This measure can not only benefit the majority of patients, but also promote assisted reproductive technology in my country

The development of technology. It is hoped that in the future, this policy will be more widely promoted, so that more families can obtain better protection when seeking assisted reproductive services, contributing to the goal of "reproductive freedom"

Give strength.